Reading Time: 5 minutes Hi, my name is Avril Mc Tague. I am undertaking a Ph.D. at Trinity College, Dublin, Ireland as part of the Multidisciplinary Innovation and Research Advancing Neurological care in a Digital Age (MIRANDA) doctoral award programme. This is funded by the Health Research Board in Ireland. I was one of five symposium communication ambassadors at last year’s international symposium.
Causes and disease mechanisms Genetic Research Markers of Disease Progression MND Research Models of MND Research we fund Treatments
Celebrating the contribution of Women to MND research
Reading Time: 7 minutes Each year the 11th of February sees the world recognise and celebrate the contributions of women in science. The International day of Women and Girls
Reading Time: 6 minutes Over the past couple of years, the pace of MND research has continued to increase. In the last year alone, we saw an increase in
Reading Time: 5 minutes Last month we held the 34th International Symposium on ALS/MND in Basel Switzerland. This huge event allows people from across the world to come and
Reading Time: 7 minutes Each year we host the International Symposium on ALS/MND in December and this is the largest medical and scientific conference specific to MND. The 34th
34th Symposium: Basel Causes and disease mechanisms Clinical Trials Events Genetic Research Healthcare Markers of Disease Progression MND Research Symposium Treatments
Reuniting the MND community at the 34th International Symposium on ALS/MND
Reading Time: 4 minutes After 3 years of online events, the MND research and healthcare community reunited in-person at the 34th International Symposium on ALS/MND in Basel, Switzerland! From
34th Symposium: Basel Causes and disease mechanisms Clinical Trials Genetic Research MND Research Symposium Treatments
Symposium Preview: Meet the ALS/FTD Plenary Speakers…Part 2
Reading Time: 5 minutes Every year, the team works hard to build on the previous year’s success. This year we are excited to include a series of three ALS-FTD joint sessions, in collaboration with the International Society for Frontotemporal Dementias, in the programme. To give you a teaser of what is to come, we are taking a closer look at the plenary speakers in the ALS-FTD sessions at the Symposium. In this blog, we explore the topics they will be presenting and find out a little more about the speakers.
Reading Time: 3 minutes Hi all, my name is Kiran, and I am the newest member of the Research Team! My role within the MND Association is as a
34th Symposium: Basel Causes and disease mechanisms Markers of Disease Progression MND Research Symposium
Symposium Preview: Meet the ALS/FTD Plenary Speakers…Part 1
Reading Time: 5 minutes Every year, the team works hard to build on the previous year’s success. This year we are excited to include a series of three ALS-FTD joint sessions, in collaboration with the International Society for Frontotemporal Dementias, in the programme.
Some people with ALS, the most common form of MND, also develop a form of dementia known as frontotemporal dementia (FTD). FTD is a group of disorders where the nerve cells in two sets of lobes (frontal and temporal) in the brain are damaged. In a similar way to how motor neurones break down in MND and cause loss of function in muscles, the damage to the nerve cells in FTD causes the connections between parts of the brain to break down. As more cells become damaged and die this can lead to symptoms such as problems with memory, thinking or language, changes in mood, emotions and behaviour.